Pramipexole [pramipexol]
- Terms
-
(S)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazol
Calmolan
Oprymea
Pexapral
pramipexol-dihydrochlorid monohydrát
-
2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
2-Amino-6-propylaminotetrahydrobenzothiazole
4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine
6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
Mirapex
Pramipexol
Pramipexol Dihydrobromide, (+-)-isomer
Pramipexol Dihydrochloride, (S)-isomer
Pramipexol, (+-)-isomer
Pramipexole Dihydrochloride
Pramipexole Dihydrochloride Anhydrous
Pramipexole Hydrochloride Monohydrate
Sifrol
SND-919
A benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.
- DUI
- D000077487 MeSH Browser
- CUI
- M0170120
- CAS
- 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-
- History note
- 2019 (1989)
- Public note
- 2019; PRAMIPEXOLE was indexed under BENZOTHIAZOLES 2007-2018; and under THIAZOLES 1989-2006
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine